• Citer

Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients.

par Meuleman, Nathalie ;Stamatopoulos, Basile ;Dejeneffe, Marielle ;El Housni, Hakim ;Lagneaux, Laurence ;Bron, Dominique
Référence Leukemia, 22, 10, page (1882-1890)
Publication Publié, 2008-10

Article révisé par les pairs

• Détails
• Contenu

Titre:	Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients.
Auteur:	Meuleman, Nathalie; Stamatopoulos, Basile; Dejeneffe, Marielle; El Housni, Hakim; Lagneaux, Laurence; Bron, Dominique
Informations sur la publication:	Leukemia, 22, 10, page (1882-1890)
Statut de publication:	Publié, 2008-10
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Aged, 80 and over
	Antigens, CD38 -- analysis
	Female
	Flow Cytometry
	Humans
	Immunoglobulin Heavy Chains -- genetics
	Immunoglobulin Variable Region -- genetics
	Leukemia, Lymphocytic, Chronic, B-Cell -- blood
	Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
	Leukemia, Lymphocytic, Chronic, B-Cell -- mortality
	Lipoprotein Lipase -- analysis
	Male
	Middle Aged
	Mutation
	Polymerase Chain Reaction
	Prognosis
	Prospective Studies
	Receptors, IgE -- blood
	Time Factors
	ZAP-70 Protein-Tyrosine Kinase -- analysis
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0887-6924
	info:doi/10.1038/leu.2008.190
	info:pii/leu2008190
	info:scp/54049108824
	info:pmid/18633433